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Abstract
 
Germinal centers are critical for affinity maturation of antibody (Ab) responses. This process al-
lows the production of high-efficiency neutralizing Ab that protects against virus infection and
bacterial exotoxins. In germinal centers, responding B cells selectively mutate the genes that
encode their receptors for antigen. This process can change Ab affinity and specificity. The mu-
tated cells that produce high-affinity Ab are selected to become Ab-forming or memory B cells,
whereas cells that have lost affinity or acquired autoreactivity are eliminated. Normally, T cells
are critical for germinal center formation and subsequent B cell selection. Both processes in-
volve engagement of CD40 on B cells by T cells. This report describes how high-affinity B
cells can be induced to form large germinal centers in response to (4-hydroxy-3-nitrophenyl)
acetyl (NP)-Ficoll in the absence of T cells or signaling through CD40 or CD28. This requires
extensive cross-linking of the B cell receptors, and a frequency of antigen-specific B cells of at
least 1 in 1,000. These germinal centers abort dramatically at the time when mutated high-
affinity B cells are normally selected by T cells. Thus, there is a fail-safe mechanism against au-
toreactivity, even in the event of thymus-independent germinal center formation.
Key words: quasimonoclonal mice • (4-hydroxy-3-nitrophenyl)acetyl–Ficoll • germinal 
centers • CD40 ligation • thymus independent
 
Introduction
 
Germinal centers are characteristically formed in response
to protein-based antigens, and this process is dependent on
T cell help and does not occur in athymic nude mice (1).
Thymus-independent antigens, such as the antigen formed
by haptenating the polysaccharide Ficoll, elicit strong Ab
responses in both nude and euthymic mice (2), but typically
do not induce germinal centers. Sporadic germinal centers
do appear in congenitally athymic rodents and mice lacking
all T cells (3, 4), but the basis for their production is un-
clear. In addition, some polysaccharide antigens have been
associated with germinal centers, but these have been found
to depend on T cells for their formation (5, 6).
Ligation of the B cell receptor (BCR)
 
1
 
 by antigen and T
cell help provides distinct signals that are critical in deter-
mining B cell fate and differentiation during immune re-
sponses. When B cells bind protein-based antigen, they be-
come highly efficient at seeking out and interacting with
primed T cells (7, 8). After receiving T cell help, B cells
proliferate in either follicles or extrafollicular sites (8, 9). In
extrafollicular foci, B cells express syndecan-1 (CD138 [10])
and secrete Ab as they grow; they do not mutate their Ig
genes (11). In follicles, small numbers of precursors upregu-
late expression of a ligand for peanut agglutinin (PNA [12])
and undergo massive rapid clonal expansion in forming ger-
minal centers (7). When the center of the follicle is filled, the
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AP, alkaline phosphatase; BCR, B cell re-
ceptor; BrdU, 5-bromo-2
 
9
 
-deoxyuridine; CTLA-4, CTL antigen 4;
H
 
g
 
1, human 
 
g
 
1; NP, (4-hydroxy-3-nitrophenyl)acetyl; PNA, peanut ag-
glutinin; QM, quasimonoclonal; TdT, terminal deoxynucleotidyltrans-
ferase; TUNEL, TdT-mediated dUTP nick end labeling. 
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B blasts differentiate into centroblasts, which remain as a non-
expanding population as their progeny differentiate into
nonproliferating centrocytes (7). The latter appear to be the
target for selection. The factors that promote exponential
growth, hypermutation, and selection are still not well un-
derstood. Blocking CD40 ligation with protein antigens
around the time of immunization inhibits germinal center
formation (13, 14), and blockade applied to established ger-
minal centers causes their dissolution (14). The finding that
B cells in certain circumstances may express CD40 ligand
(15, 16) has raised the possibility that this effect is not due
to interference in T cell–B cell interactions. In this study,
we show that in exceptional circumstances germinal cen-
ters can be formed reproducibly in the absence of T cells.
Although this does not represent the normal way germinal
centers are induced, it does allow us to determine if T cell–
derived signals are indispensable at particular stages.
The model for T cell–independent germinal center forma-
tion described in this report uses mice with transgenic BCRs
that have high affinity for the hapten (4-hydroxy-3-nitro-
phenyl)acetyl (NP), quasimonoclonal (QM) mice (17), and
their response to the thymus-independent type 2 antigen,
NP-Ficoll. NP-Ficoll characteristically does not induce
germinal centers in normal mice (18–21). QM mice carry a
rearranged VDJ IgH chain V region in the J4 H chain locus
(17). Expression of this transgene in combination with 
 
l 
 
L
chains results in BCRs with high affinity for NP. 60% of
peripheral B cells in these mice are specific for NP, and
other specificities result from diversification of the repertoire
by somatic mutation and V gene replacements (22). Conse-
quently, the mice remain immunocompetent (23) and form
small non–NP-specific germinal centers in the absence of
immunization, presumably in response to environmental
antigens. Immunization of these mice intraperitoneally with
NP-Ficoll causes an impressive extrafollicular Ab response,
and also induces large germinal centers in all splenic folli-
cles. This report investigates the way these germinal centers
are induced, and shows that T cells are not required until
the stage when centrocytes are normally selected.
 
Materials and Methods
 
Animals and Experimental Procedures. 
 
All mice were bred and
maintained in specific pathogen-free conditions at the University
of Birmingham. QM mice were generated on a 129 background
(17) and backcrossed onto C57BL/6. To study the effects of CD80/
CD86 signaling on germinal center formation, QM mice were
crossed with CTL antigen 4 (CTLA-4)–human 
 
g
 
1 (H
 
g
 
1) mice
with the same C57BL/6 background (24). Approximately 50% of
the F
 
1
 
 mice from this mating have the transgene as assessed by he-
magglutination for H
 
g
 
1 in the serum. Nontransgenic littermates
were used as controls. These transgenic mice were provided by
Dr. Peter Lane of the Center for Immune Regulation (Birming-
ham, UK).
C57BL/6 mice were obtained from Harlan, Ltd. (QM 
 
3
 
C57BL/6)F
 
1
 
 recipients and congenic littermate controls that lacked
the VDJ 17.2.25 insertion (J
 
H
 
1
 
/
 
2
 
, 
 
k
 
1
 
/
 
2
 
, 
 
l
 
1
 
/
 
1
 
) were used for cell
transfer experiments. Mice were immunized between 6 and 16 wk
of age. Unless otherwise stated, immunizations were by intraperito-
neal injection with 30 
 
m
 
g NP-Ficoll or 50 
 
m
 
g alum-precipitated
chicken 
 
g
 
-globulin (Sigma Chemical Co.), plus 10
 
9
 
 heat-inactivated
 
Bordetella pertussis 
 
bacteria. In the CD40 blocking experiments, mice
received either 250 
 
m
 
g of the anti–CD40 ligand mAb MR1 (Amer-
ican Type Culture Collection [13]) intraperitoneally, or hamster
IgG as a control (Pierce Chemical Co.), on days 0.5, 1, and 3 after
immunization. To label cells in S phase of the cell cycle, mice were
given 2 mg of 5
 
9
 
-bromo-2-deoxyuridine (BrdU; Sigma Chemical
Co.) intraperitoneally 2 h before the spleens were removed.
 
Cell Transfers. 
 
Single-cell suspensions were prepared from
donor spleens by gently sieving spleens through nylon mesh. QM
mouse–derived donor splenocytes were analyzed by flow cytom-
etry before transfer to determine the proportion of NP-specific B
lymphocytes in the cell suspension. Donor splenocytes, in the
numbers specified in Results, were suspended in 0.2 ml of PBS
and injected into the lateral tail vein of nonirradiated recipients.
Recipients were immunized with 30 
 
m
 
g NP-Ficoll 24 h after the
cells were transferred.
 
Generation of QM Fetal Liver Irradiation Chimeras. 
 
CBA/c nude
recipient mice were irradiated (400 cGy), then reconstituted 6 h
later by intravenous injection of 3 
 
3 
 
10
 
6
 
 fetal liver cells obtained
from day 17 QM mouse embryos. Mice were immunized 6 wk
after reconstitution.
 
Abs and Reagents Used for Immunohistology and Flow Cytometry.
 
The following antibodies and reagents were used: rat anti–mouse
monoclonal IgM (LO-MM-9; Serotec), sheep anti–mouse IgD
(The Binding Site), syndecan-1 (CD138; PharMingen), rat anti–
mouse CD3 (PharMingen), biotinylated PNA (Vector Labs), bio-
tinylated mouse anti–mouse anti–Bcl-6 (Santa Cruz Biotechnol-
ogy), NP conjugated to rabbit or sheep IgG (produced in our
laboratory), rat Ab against the QM IgH idiotype R2.248 (gift
from Dr. T. Imanishi-Kari, Tufts University School of Medicine,
Boston, MA), mouse anti-BrdU (Dako), biotinylated or peroxidase-
conjugated rabbit anti–rat IgG, rabbit anti–sheep IgG-biotin, goat
anti–mouse IgG-biotin, pig anti–rabbit IgG-biotin (Dako), don-
key anti–sheep IgG–horseradish peroxidase (The Binding Site),
streptavidin-CyChrome (PharMingen), NP-PE (conjugated in
our laboratory), and B220-FITC (PharMingen). The succinimide
ester of 3-nitro-4-hydroxy-3-phenyl acetate was conjugated to
Ficoll (Biosearch Technologies).
 
Flow Cytometry. 
 
Cells were maintained in the dark at 4
 
8
 
C
throughout the staining procedure. Red cells were lysed using
Gey’s solution. Data were acquired on a Coulter EPICS
 
®
 
 XL-MCL
flow cytometer, and analyzed using WinMDI 2.7 software.
 
Immunohistology. 
 
Immunohistology was performed as described
previously (8, 21). In brief, frozen sections of spleen were air
dried; primary Abs were added to sections, followed after wash-
ing by secondary reagents. When biotin-conjugated reagents
were used, StreptABComplex/alkaline phosphatase (AP; Dako)
was added after another wash. Horseradish peroxidase activity
was detected using diaminobenzedine tetrahydrochloride solution
(Sigma Chemical Co.). AP activity was detected using naphthol
AS-MX phosphate (Sigma Chemical Co.) and chromogen Fast
Blue BB salt (Sigma Chemical Co.) in 50 mM Tris-buffered sa-
line (pH 9.2) containing 0.8 mg/ml levamisole to block endoge-
nous AP activity (Sigma Chemical Co.). To detect cells that had
incorporated BrdU, sections were treated with 0.1 M HCl
(Sigma Chemical Co.) at 60
 
8
 
C for 20 min to make the BrdU-
containing DNA accessible to the anti-BrdU Ab (Dako). Bound
Ab was detected with biotin-conjugated goat anti–mouse Ig fol-
lowed by StreptABComplex/AP. Enzyme activity was demon-
strated using naphthol AS-MX phosphate with Fast Red TR salt
(Sigma Chemical Co.). Slides were mounted in glycerol jelly. 
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Cells undergoing apoptosis were detected by terminal deoxy-
nucleotidyltransferase (TdT)-mediated dUTP nick end labeling
(TUNEL) staining. Frozen sections were fixed in 3% paraformal-
dehyde for 3 min at room temperature, then washed twice in
PBS. TdT buffer (80 
 
m
 
l; GIBCO BRL) was added for 15 min,
and then 60 
 
m
 
l of warm TdT mix (5% TdT buffer, 0.2 nM
digoxigenin-11-dUTP; Boehringer Mannheim), 5 U TdT (Boeh-
ringer Mannheim), and 2 mM dATP (Promega) were added. The
slides were incubated for 40 min at 37
 
8
 
C in a humidified cham-
ber. Slides were washed twice in 0.5 mM EDTA, 2% BSA (pH
8.0). Antidigoxigenin Fab fragments conjugated to AP (Boeh-
ringer Mannheim) were added at 1:50 in blocking solution (5
 
3
 
SSC, 5% nonfat milk powder, 0.15% Triton X-100) and incu-
bated for 30 min at room temperature, then washed and devel-
oped as described above. Double stainings with rat anti–mouse
IgM were carried out as described above.
 
Quantification of Immunohistology.
 
 
 
The germinal centers were
stained with PNA, and the extrafollicular plasmablasts were iden-
tified by the high content of cytoplasmic Ig and expression of
syndecan-1. The NP specificity or idiotype staining was checked
in adjacent tissue sections. The relative areas in square millimeters
were determined using a point counting technique (25). An ap-
proximation of the total number of positively identified cells per
cubic millimeter was calculated as the cube of the square root of
the number of cells per spleen area. The values obtained were
corrected for spleen mass to give relative volumes.
 
NP-specific Ab ELISA. 
 
Serum NP-specific IgM, IgG1, IgG2a,
IgG2b, and IgG3 Ab titers were assessed by ELISA using 4-hydroxy-
3-iodo-5-nitrophenyl (NIP)-BSA–coated and BSA-blocked
plates. Bound Ab was detected using AP-conjugated rat Abs
against the appropriate mouse Ig isotype (Sigma Chemical Co.).
The amount of enzyme bound to each well was quantitated using
a phosphatase substrate system (Kirkegaard & Perry Laboratories).
Standard calibration curves were plotted from the positive con-
trol sera, and the test serum titers were calculated as an OD
 
50
 
 of
these standard controls.
 
Cell Culture. 
 
B cells were purified from spleen by magnetic de-
pletion of CD43
 
1
 
 cells using the VarioMacs system (Miltenyi Bio-
tec). This resulted in B cell purity of 
 
.
 
97%. Cells were cultured in
RPMI, 10% FCS. 5 
 
3 
 
10
 
5
 
 cells were added to each well of a sterile
flat-bottomed 96-well plate, stimulated with NP-Ficoll with or
without anti-CD40 mAb (3.23), and cultured at 37
 
8
 
C in 5% CO
 
2
 
.
 
Results
 
Germinal Centers Form in QM Mice in Response to Immuni-
zation with NP-Ficoll. 
 
When QM mice are immunized
intraperitoneally with 30 
 
m
 
g of the polysaccharide antigen
NP-Ficoll, they form germinal centers in the spleen (Fig. 1,
a–d). These germinal centers are large and can be found in
every follicle, but contain very few T cells (Fig. 1, c and d).
The phenotype of B cells in NP-Ficoll–induced germinal
centers is indistinguishable from germinal centers induced
by conventional protein antigen (12, 26). They stain with
PNA, downregulate IgD and B220, and express Bcl-6. The
large size and paucity of T cells contrast with background
germinal centers seen in QM mice. The background ger-
minal centers are not NP specific; they are small, and con-
tain normal numbers of T cells (Fig. 1, a and b).
The kinetics of NP-Ficoll–induced germinal center for-
mation in QM mice were analyzed by flow cytometry and
immunohistology. By 2 d after immunization, PNA
 
high
 
 NP-
specific B cells are detectable by flow cytometry (Fig. 2). At
this time, PNA
 
high
 
 B cells already represent 
 
.
 
20% of B220
 
1
 
B cells. NP-specific germinal centers are clearly detectable
immunohistologically by 72 h, when large clusters of NP-
binding PNA
 
high
 
 blasts fill the follicles (Fig. 1 c). Growth of
the germinal centers continues through day 4, when they
approach their maximum size (Fig. 3). By 96 h, pulse label-
ing for 2 h with BrdU shows demarcation of dark zones,
with many BrdU
 
1
 
 centroblasts, and light zones containing
the follicular dendritic cell network and few BrdU
 
1
 
 cells.
The kinetics and peak sizes of NP-Ficoll–induced germinal
centers in QM mice up to this stage are very similar to those
found in responses to haptenated protein when primed T
cells are made available at the time of challenge through
prior immunization with carrier (7, 8).
 
NP-Ficoll–induced Germinal Center B Cells Undergo Apoptosis
at the Stage When Centrocytes Start to Be Selected.
 
The simi-
larity with normal germinal centers ends on day 5, when the
NP-Ficoll–induced germinal centers in QM mice abort
synchronously. Within 24 h (by day 6), no trace of germi-
nal centers remains (Fig. 1 h, and Fig. 3). This dissolution is
associated with progressive loss of proliferating cells and
massive apoptosis among the remaining centrocyte popula-
tion. To confirm the morphological evidence of apoptosis,
spleen sections were subjected to TUNEL staining through-
out the time course of the germinal center reaction. Al-
though very few nuclei stained positive on day 4, a large
number of germinal center cells was stained on day 5 (Fig.
1 g). Possible interpretations of this sequence of events are
set out in the Discussion.
 
Germinal Centers Induced by NP-Ficoll in QM Mice are
Thymus Independent. 
 
Ab responses to NP-Ficoll are inde-
pendent of T cell help, as they occur normally in nude
mice and in mice that are T cell deficient because of dis-
ruption of the 
 
b
 
 and 
 
d
 
 TCR genes. Several observations
suggest that the germinal centers induced in QM mice by
NP-Ficoll are also T cell independent. First, the germinal
centers are only formed in primary T cell–dependent re-
sponses to protein-based antigens after T cell priming has
occurred. The lag of 2–3 d associated with priming is not
seen in the germinal centers induced by NP-Ficoll in QM
mice, where the kinetics match those seen when T cell
help is immediately available (7, 8). Second, very few or no
T cells are present in the NP-specific germinal centers in
QM mice (Fig. 1 d). Finally, the NP-specific Ab response
in QM mice immunized with NP-Ficoll is predominantly
IgM and IgG3 (Table I), the isotype pattern associated with
lack of T cell help in response to thymus-independent type
2 antigens in normal (27) and T cell–deficient mice (Table I).
The thymus independence of germinal center formation
by QM mouse B cells responding to NP-Ficoll was tested in
nude mouse chimeras. Adult nude mice were subject to 400-
cGy total body irradiation, followed by transfer of QM fetal
liver as a source of hemopoietic cells. The resulting chimeras
had donor-derived B cells, but no thymus-processed T cells.
6 wk after transfer, the QM nude chimeras were immunized
intraperitoneally with 30 
 
m
 
g NP-Ficoll. Large NP-specific
germinal centers formed in splenic follicles (Fig. 1, e and f). 
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Figure 1.
 
The formation and demise of germinal centers in QM mouse splenic follicles in response to NP-Ficoll. (a and b)
 
 
 
Sections of spleen from
nonimmunized QM mice. NP-specific cells (blue) in the follicular mantle and marginal zones surround a small germinal center, which is not NP-spe- 
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NP-Ficoll–induced Germinal Centers Are Independent of CD40
Ligation or Signaling Triggered by CD80 or CD86. 
 
CD40 sig-
naling is critical for the formation of germinal centers in
normal mice immunized with protein-based antigens (13,
14, 28, 29). In addition, mice unable to signal through
CD80 or CD86 engagement of CD28 or CTLA-4 fail to
form germinal centers in response to protein antigens (24,
30). The experiments described above indicate that NP-
Ficoll–induced germinal centers in QM mice are T cell inde-
pendent, but it was important to exclude a role for CD40
ligand expressed by B cells or another type of cell in the ab-
sence of T cells. This was tested in (QM 
 
3
 
 C57BL/6)F
 
1
 
mice, which also form germinal centers in response to NP-
Ficoll, and form germinal centers normally after immuniza-
tion with alum-precipitated chicken 
 
g
 
-globulin. The effect
of blocking Ab against CD40 ligand on germinal centers to
these two antigens was compared: 250 
 
m
 
g blocking Ab
MR1 was given to mice 12 h before and 24 and 72 h after
immunization with either antigen. Consistent with previ-
ous reports, the formation of germinal centers after protein
immunization was reduced to 
 
,
 
5% of that in mice given
control Ab (Fig. 3 a). The blocking Ab had only a small ef-
fect on germinal centers formed in response to NP-Ficoll
(Fig. 4 a); the small but significant effect might reflect an
enhancing role for non–T cell CD40 ligand in germinal
center formation. The effect of CD40 signaling on NP-
specific QM mouse B cells exposed to NP-Ficoll was then
assessed in vitro. Dilutions of NP-Ficoll were added to pu-
rified QM splenic B cells with and without added mAb
against CD40. On culture, high level PNA binding devel-
oped in B cells exposed to NP-Ficoll alone; the addition of
CD40 enhanced this effect (Fig. 5).
Further studies were made to test whether CD28 signal-
ing is required for the formation of germinal centers in QM
mice immunized with NP-Ficoll. Mice constitutively ex-
pressing the CTLA-4–H
 
g
 
1 transgene were crossed to QM
mice. The response to NP-Ficoll by their progeny express-
ing the transgene was compared with that in their trans-
gene-negative littermates. The CTLA-4–H
 
g
 
1 fusion pro-
tein is an effective competitive inhibitor of CD86 or CD80
engagement of CD28; mice carrying this transgene do not
form germinal centers in response to protein-based antigens
in otherwise normal mice (24, 30). The presence of the
CTLA-4–H
 
g
 
1 fusion protein did not prevent (QM 
 
3
 
CTLA-4–H
 
g
 
1)F
 
1
 
 hybrids from forming germinal centers
in response to NP-Ficoll (Fig. 4 b).
 
Minimum Requirements for T Cell–independent Germinal
Centers: Antigen-specific Precursor Frequency and Antigen Dose.
 
The experiments described above establish that NP-Ficoll–
induced germinal centers in QM mice are independent of
T cell help and CD40 ligation. The question remains: why
do B cells from QM mice form germinal centers, whereas
those in congenic nontransgenic littermates do not? There
are two important characteristics of QM mice, not found in
conventional mice, that could provide an explanation. First,
QM mice have an abnormally high number of antigen-spe-
cific cells. Second, the transgene-encoded antigen receptors
 
cific (a) and contains normal numbers of CD3
 
1
 
 T cells (blue,
 
 
 
b). Red-stained nuclei of cells in the germinal center have taken up BrdU, given to mice
2 h before the spleen was taken. (c and d)
 
 
 
Sections of spleen from QM mice after intraperitoneal immunization with NP-Ficoll. Large T cell–independent
germinal centers are PNA
 
1
 
 (blue, c) and contain few CD3
 
1
 
 T cells (blue, d). (e and f)
 
 
 
Sections of spleen from QM nude mouse chimeras 4 d after intra-
peritoneal immunization with NP-Ficoll. Germinal centers are PNA
 
1
 
 (blue, e) and contain NP-binding B cells (blue, f). Heavy blue staining in the red
pulp and around the central arteriole are NP-specific plasmablasts.
 
 
 
(g) TUNEL staining (blue) of a germinal center in spleen from a QM mouse 5 d after
intraperitoneal immunization with NP-Ficoll. (h)
 
 
 
Section of spleen from a QM mouse in which no germinal centers can be seen 6 d after intraperitoneal
immunization with NP-Ficoll. G, germinal center; T, T zone; R,
 
 
 
red pulp.
Figure 2. Three-color flow cytometric analysis of splenic B cells from
QM mice before (a and b) and 2 d after (c and d) intraperitoneal immuni-
zation with 30 mg NP-Ficoll. Lymphocytes were gated on forward and
side scatter, and then PNA expression and NP binding (b and d) were an-
alyzed on B2201 cells (a and c). The percentages of NP-binding B cells
that are also PNAhigh are shown.
Figure 3. Kinetics of germinal center formation in spleens from QM
mice after intraperitoneal immunization with 30 mg NP-Ficoll. Spleens
were taken at the indicated times after immunization. Each dot represents
the total volume in 1 mm3 of NP-specific germinal centers in the spleen
from one mouse. 
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have a uniform high affinity for NP. These two factors
could increase the strength of signals delivered to the B
cells, either via the high-avidity interaction between antigen
and BCR, or because increased numbers of antigen-reac-
tive cells could result in autocrine potentiation of responses.
To investigate these possibilities, we assessed the minimum
frequency of NP-specific QM B cells and the minimum
dose of antigen required to induce (a) an extrafollicular
plasmablast response and (b) a germinal center reaction.
Serial dilutions of QM spleen cells were transferred into
nonirradiated congenic recipients, which were then immu-
nized with NP-Ficoll (Fig. 6 a). The numbers of NP-spe-
cific B cells in the inocula were determined by flow cytom-
etry before the cells were transferred. NP-specific germinal
centers and extrafollicular responses, identified by their ex-
pression of donor-specific H chain idiotype, formed in mice
that had received 1 
 
3 105 or more NP-specific QM B
cells. Recipients of 3 3 104 B cells produced an extrafollic-
ular response, but no germinal centers. In the next experi-
ment, intact (QM 3 C57BL/6)F1 mice were immunized
with graded doses of NP-Ficoll. Mice immunized with 0.3
and 1 mg of NP-Ficoll made an extrafollicular response, but
did not form NP-specific germinal centers. Immunization
with doses of 3 mg NP-Ficoll or more induced both germi-
nal centers and extrafollicular responses (Fig. 6 b).
Discussion
The studies reported indicate that there is no absolute re-
quirement for T cell–derived signals for the induction of
germinal centers and acquisition of the germinal center B
cell phenotype. Further, these signals are necessary for nei-
ther the exponential phase of B cell growth nor the differ-
Figure 4. The effect of CD40, CD80, and CD86 blockade on germi-
nal center formation. (a) Volume of germinal centers in spleens from
(QM  3 C57BL/6)F1 mice 4 d after intraperitoneal immunization with 30 mg
NP-Ficoll (right) or 10 d after intraperitoneal immunization with 50 mg
alum-precipitated chicken g-globulin (CGG), plus 1 3 109 killed B. per-
tussis bacteria (left). Mice represented by the black bars were given 250 mg
of MR1 (reference 13), a hamster anti–mouse CD40 ligand mAb, on days
20.5, 1, and 3 after immunization; white bars show values for control
mice receiving normal hamster Ig. The values shown by the gray bars are
responses of mice receiving no Ig. (b) Volume of germinal centers in
spleens from (QM 3 CTLA-4–Hg1 transgenic)F1 mice 4 d after intra-
peritoneal immunization with 30 mg NP-Ficoll. Values for mice carrying
the CTLA-4–Hg1 transgene are shown by the gray bar, and those for
congenic littermates without the transgene are shown by the hatched bar.
Figure 5. Induction of PNA
on QM B cells after stimulation
in vitro.  Purified QM B cells
were cultured with graded doses
of NP-Ficoll with or without
anti-CD40 Ab (0.1 mg/ml 3.23).
Cultures were harvested on day
2, and the percentage of PNAhigh
cells was determined by flow cy-
tometry. (a) Representative his-
tograms of PNA binding gener-
ated by flow cytometric analysis
of gated B2201 cells that were
stimulated with NP-Ficoll (left)
or NP-Ficoll and anti-CD40
(right). In each case, black over-
lays show that there was minimal
induction of PNA-binding B cells
in cultures without NP-Ficoll. (b)
Summary of induction of PNA-
binding cells by NP-Ficoll (s), or
NP-Ficoll plus anti-CD40 (j).
Figure 6. Antigen dose and B cell precursor frequency required to
form germinal centers. (a) Volume of NP-specific germinal centers (d)
and extrafollicular foci (s) in spleens obtained from nonirradiated con-
genic recipients of the indicated number of QM-derived B cells 4 d after
intraperitoneal immunization with 30 mg NP-Ficoll. NP-specific germi-
nal center volumes in spleens obtained from intact QM and (QM 3
C57BL/6)F1 mice 4 d after intraperitoneal immunization with 30 mg NP-
Ficoll are also shown. (b) Volume of NP-specific germinal centers (d)
and extrafollicular responses (s) in spleens obtained from (QM 3
C57BL/6)F1 mice 4 d after intraperitoneal immunization with the indi-
cated quantities of NP-Ficoll.
Table I. Median Serum Class and Subclass Anti-NP Ab Titers 
Produced in Response to NP-Ficoll
C57BL/6 QM
Days after immunization 0 5 7 0 5 7
Log2 anti-NP titer
IgM ,0 8 9 4 19 16
IgG1 ,02 ,09
IgG2a ,0 ,04 0
IgG2b ,00 ,0 ,0
IgG3 ,08 ,01 4
Six C57BL/6 mice and four QM mice were studied at each time point
after intraperitoneal immunization with 30 mg NP-Ficoll.491 García de Vinuesa et al.
entiation of germinal centers into dark and light zones. The
spontaneous involution of the germinal centers on day 5
might reflect the absence of T cell signals, which are re-
quired for physiological germinal center maturation, at the
time of initial B cell activation. Alternatively, the loss of
germinal centers on day 5 might reflect failed centrocyte
selection.
Previous studies have shown involution of established
germinal centers by CD40 blockade, and this provided the
most compelling evidence that T cells are required for pos-
itive selection of germinal center B cells (14). The possible
role of B cell–expressed CD40 ligand in maintaining ger-
minal centers could not be excluded as an explanation for
this result. The results of the present study are consistent
with the view that T cell–derived signals are required to
sustain germinal centers; if B cell CD40 ligand has a role in
germinal center maintenance, it must be in addition to
CD40 ligation delivered by T cells.
How are T cells involved in maintaining germinal cen-
ters? B cells in germinal centers proliferate as centroblasts in
the dark zone, which is largely devoid of T cells; they then
come out of cell cycle as centrocytes and enter the light
zone (31). In the light zone, centrocytes can bind antigen
held on follicular dendritic cells and present this to the
abundant T cells, which are found at the outer edge of this
compartment (32). Kepler and Perelson developed a math-
ematical model predicting that successive rounds of hyper-
mutation and selection are necessary to account for the ki-
netics of affinity maturation (33). In practice, this is likely to
result from hypermutation being active in centroblasts,
which only undergo a finite number of divisions before ma-
turing into centrocytes. If this is the case, the pool of centro-
blasts will be rapidly exhausted unless it is renewed from a
proportion of the centrocytes that are positively selected in
the light zone. In the NP-Ficoll–induced germinal centers of
QM mice, the antigen is not processed and presented to T
cells; consequently, selection is not possible and centroblasts
are not renewed. This gives us a tentative indication of the
number of cell divisions centroblasts go through before dif-
ferentiating to centrocytes, as the period between the ap-
pearance of the dark zone and germinal center dissolution is
between 24 and 36 h. Allowing for the time centrocytes take
to die, the lifespan of centroblasts is likely to be 18–24 h, suf-
ficient time for three to four cell cycles (34).
Studies of cocultures of human centrocytes with autolo-
gous germinal center T cells show that T cells can prevent
centrocytes from entering apoptosis, and induce differenti-
ation of a proportion of the cells to centroblasts, whereas
others acquire a memory B cell phenotype (35). In addition
to lack of centroblast renewal, failed selection of centro-
cytes will also prevent memory B cells and plasma cells
from emerging from the germinal centers. This provides a
fail-safe mechanism that prevents the emergence of cells
rendered autoreactive by hypermutation from germinal
centers formed in the absence of T cell help.
An alternative explanation for the demise of germinal
center cells induced in QM mice by NP-Ficoll is that they
are negatively selected by signals delivered through the
BCR. Precedents for this mechanism are provided by the
studies that indicate that massive death is induced in estab-
lished germinal centers by giving large amounts of the anti-
gen used to induce the germinal center (36–38). This phe-
nomenon appears to differ in three ways from the sudden
death that occurs in germinal center B cells during the QM
mouse response to NP-Ficoll. First, large amounts of anti-
gen (4 mg [38] or 5 mg [36, 37]) were required to induce
the dissolution of established germinal centers. By contrast,
germinal centers were induced in QM mice by a single in-
jection of 3 mg NP-Ficoll (Fig. 6). Some NP-Ficoll–con-
taining immune complex is identified immunohistologi-
cally on follicular dendritic cells. As this antigen induces a
particularly strong cross-linking signal, it might be argued
that this is sufficient to induce apoptosis of germinal center
cells. The second difference militates against this possibility,
since high-dose antigen induces apoptosis of germinal cen-
ter cells within 3 h (38). This timing is hardly consistent
with that of cell death in the germinal centers in the NP-
Ficoll response, which starts only at the end of the day 4
after immunization. Third, the effect of high-dose soluble
antigen on germinal center cells is dramatic, but is not com-
plete, and there is some subsequent recovery (38); however,
the loss of germinal center B cells in QM mice is complete
and permanent.
Transfer of QM B cells into intact recipients reveals a
precursor frequency threshold for the T cell–independent
germinal center formation induced by NP-Ficoll. Germinal
centers were observed when the frequency of NP-specific
B cells reached 1:1,000 B cells. In conventional mice that
have undergone repeated immunization with NP–chicken
g-globulin, the number of high-affinity NP-specific mem-
ory B cells may well be .1:1,000. Nevertheless, when
these mice are immunized with NP-Ficoll, they only form
extrafollicular Ab responses (39). This suggests that mem-
ory cells may be resistant to being induced to form germi-
nal centers, and supports the circumstantial evidence that
virgin B cells have a greater predilection than memory B
cells for giving rise to germinal centers (for a review, see
reference 40).
The threshold number of antigen-specific cells required
to form germinal centers might reflect cross-talk between B
cells associated with the presence of increased numbers of
responding B cells, either at the time of B cell activation or
within nascent germinal centers. This could be through in-
teraction between cell surface molecules or secreted cyto-
kines or both. The studies with CD40 ligand neutralization
reported here make a critical role for CD40 ligation by B
cell interaction with B cells unlikely. Another possibility is
interaction between the CD11a, CD18 heterodimer, and
CD54 (41). There are several potential B cell autocrine ef-
fects that could involve cytokines; these include the pro-
duction of IL-10 and IL-6 (42, 43).
We have also demonstrated an antigen threshold; doses
of NP-Ficoll ,3 mg/ml stimulated extrafollicular responses,
but not germinal center formation. Since there are thresh-
olds for antigen-specific precursor frequency and antigen
dose, NP-Ficoll–induced germinal center formation in492 Germinal Centers without T Cells
QM mice may also reflect an exceptionally strong signal de-
livered through BCRs because of B cell–B cell cross-link-
ing via NP-Ficoll. Precedents for an altered outcome re-
sulting from B cells binding membrane-bound versus
soluble antigen are provided by studies of immature B cells
in the marrow. When these bind antigen expressed by an-
other cell (44, 45) or are agglutinated by anti-IgM (46, 47),
they die in situ. If, on the other hand, they bind soluble an-
tigen, they leave the marrow for secondary lymphoid tis-
sues where they can elicit and respond to T cell help (48).
As well as identifying the minimal requirements for ger-
minal center formation, these experiments reveal that the
threshold of signaling for B cells to mount an extrafollicular
response in the absence of T cells is substantially lower than
that required for germinal center formation. An explana-
tion has yet to be found for why some B cells differentiate
into Ab-forming cells in extrafollicular foci, and others
form germinal centers.
This model for germinal center formation provides the
opportunity to assess whether T cells are critical in activat-
ing somatic mutation in germinal center cells, or whether
this is triggered by the same signals that induce B cell
growth in follicles. Currently, studies are underway com-
paring the appearance of Ig V region mutations in T cell–
dependent and –independent germinal centers. The use of
carrier priming to induce synchronous early T cell–depen-
dent NP-specific germinal center formation allows direct
comparison with germinal centers formed in QM mice.
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